University of Cincinnati Brain Tumor Center
Events and News
Highlights from Research Team accomplishments and Center announcements.
Expressive Music Therapy for Chemobrain delivered on mobile devices.
Dr. Soma Sengupta MD PhD of the UC COM Department of Neurology & Rehabilitation Medicine, Harold C. Schott Endowed Chair of Molecular Therapeutics, and Associate Dean, Dr. Claudia Rebola PhD of the UC College of Design, Architecture, Art, and Planning (DAAP), have developed an App to deliver music therapy for patients who are affected by chemobrain. They are currently beta-testing the App, known as ARMCAN since they wish to counteract persistent declines in memory or other brain functions following chemotherapy.
Their collaborators include neurocognitive neurology's, Dr. R. Shatz DO of the UC COM Department of Neurology & Rehabilitation Medicine, and Dr. A. Mahammdi, Assistant Professor in Neuroradiology. Yehudit Rothman PA, for neuro-oncology and cancer survivorship, will be carrying out the study.
This study was made possible by funding through the UCGNI, Brain Tumor Center Funds.
Please contact Jamie Denlinger, brain tumor center nurse navigator if you are interested in participating in this study cell: 513-475-5080, Monday to Friday, 8 am-5 pm.
More descriptions of the research can be found on the following websites:
Local 12 News Cincinnati
Huffman Visiting Professors at the UC Brain Tumor Center May 27th.
Drs. Maria Castro PhD and Pedro Lowenstein MD PhD of the Department of Neurosurgery at the University of Michigan presented the 2021 Huffman Visiting Professor lectures on Thursday May 27th at 12:00 noon. Thank you Drs. Castro and Lowenstein for sharing your outstanding insights!
B*CURED grant award
Congratulations to Matthew Garrett MD PhD on the award of a B*CURED & NREF Research Fellowship Grant/Young Clinician Investigator Award!
> Read more at the Neurosurgery Research and Education Foundation (NREF) website.
Novel strategy to enhance radiotherapy and immune checkpoint therapy
Congratulations Daniel Pomeranz Krummel PhD and Soma Sengupta MD PhD FRCP on the publication of GABAa agonist treatment to enhance the efficacy of radiotherapy and immune checkpoint inhibitor therapy in brain metastatic melanoma, published in the International Journal of Radiation Oncology, Biology, Physics.